Process / pipelineIn vivo angiogenesis model
CAM Assay
The chorioallantoic membrane (CAM) assay is a well-established in vivo model for studying angiogenesis (new blood vessel formation) and evaluating the pro- or anti-angiogenic properties of biomaterials, drugs, and bioactive molecules. Developed by Judah Folkman in the 1970s, the assay uses the highly vascularized CAM of developing chick embryos as a platform for implanting test materials and observing vascular response. The CAM provides a transparent, immunologically naive microenvironment with rapid and reproducible neovascularization, making it ideal for screening angiogenic potential and assessing biomaterial biocompatibility.
Open in MethodMindSoonVideoSoon
Read the full method
Members only
Sign inSign in with a free account to read this section.
Sources
- Folkman, J. (1974). Tumor angiogenesis: therapeutic implications. New England Journal of Medicine, 285(21), 1182-1186. DOI: 10.1056/NEJM197405162852108 ↗
- Ribatti, D. (2016). The chick embryo chorioallantoic membrane (CAM) assay. Current Protocols in Immunology, 15, 12.1-12.13. DOI: 10.1002/cpim.3 ↗
- Norris, C. S., Griffith, O. W., & Reid, L. M. (2003). The chorioallantoic membrane (CAM) as a model for angiogenesis. In Antiangiogenic Agents in Cancer Therapy. Humana Press, pp. 463-477. DOI: 10.1385/1-59259-413-X:463 ↗